Guest guest Posted February 1, 2012 Report Share Posted February 1, 2012 In the absence of any large-scale published randomized study comparing prostate cancer treatments, perhaps the most thorough and objective literature review attempting such a comparison was the one done by the Prostate Cancer Results Study Group. A summary is on Dr. Grimm's web site: http://www.prostatecancertreatmentcenter.com/ProstateCancer/ProstateCancerResult\ sStudyGroup.aspx I find it a bit bemusing that this study is often criticized as being 'biased' towards brachytherapy when the results are presented by Drs. Grimm or Blasko, or shown on a brachytherapy web site. The actual study group was composed of 25 highly respected doctors including surgeons, radiologists, oncologists, and medical researchers. The study group had very restrictive conditions for inclusion of the studies reviewed-- only those providing stratification of treatment results by risk group, only studies published in peer reviewed journals, only studies meeting a minimum number of patients. The graphical summaries showing treatment results by risk group are fully documented with references and are rather eye-opening in the range of actual treatment outcomes for each treatment type and risk group. As a prostate cancer patient yet to be treated (6 years into Active Surveillance), and thus as yet having no bias towards MY treatment choice, I am following the continuing study by this group with great interest. I can highly recommend that any man facing the tough issue of chosing treatment for prostate cancer take a look at the above web site. I can provide additional slides from presentations on this review if anyone wishes. The Best to You and Yours! Jon in Nevada ------------------------------ Date: Wed, 1 Feb 2012 14:20:02 -0500 Subject: Re: Surgery Next Week! Marty, if Grimm really has evidence that " Brachy +IMRT yields lower incidence of sexual dysfunction and lower incidence of incontinence, " then he should have published his findings in a peer reviewed journal article, not just on his website. I'm sure that the Dr. knows this, so, the only conclusion I can draw is that he probably did submit an article and the reviewers rejected it......................... Quote Link to comment Share on other sites More sharing options...
Guest guest Posted February 1, 2012 Report Share Posted February 1, 2012 Thanks Excellent study. Sort of a scandal at the VA Hospital near the Hospital of the Univ of Penn several years ago. Seems the radiologist implanting seeds was doing a bad job, and many seeds dislodged, or moved, causing radiation burns in unwanted places, and other adverse effects. The program was shut down while all patients were contacted and sreevaluated. Meanwhile the new proton beam machine went on line next door at HUP. So, in Philadelphia, it is my impression that brachytherapy is not getting all the support it deserves. Obviously, in selecting a surgeon, you want one with experience and lots of it. T In the absence of any large-scale published randomized study comparing prostate cancer treatments, perhaps the most thorough and objective literature review attempting such a comparison was the one done by the Prostate Cancer Results Study Group. A summary is on Dr. Grimm's web site:http://www.prostatecancertreatmentcenter.com/ProstateCancer/ProstateCancerResultsStudyGroup.aspxI find it a bit bemusing that this study is often criticized as being 'biased' towards brachytherapy when the results are presented by Drs. Grimm or Blasko, or shown on a brachytherapy web site. The actual study group was composed of 25 highly respected doctors including surgeons, radiologists, oncologists, and medical researchers. The study group had very restrictive conditions for inclusion of the studies reviewed-- only those providing stratification of treatment results by risk group, only studies published in peer reviewed journals, only studies meeting a minimum number of patients. The graphical summaries showing treatment results by risk group are fully documented with references and are rather eye-opening in the range of actual treatment outcomes for each treatment type and risk group.As a prostate cancer patient yet to be treated (6 years into Active Surveillance), and thus as yet having no bias towards MY treatment choice, I am following the continuing study by this group with great interest. I can highly recommend that any man facing the tough issue of chosing treatment for prostate cancer take a look at the above web site.I can provide additional slides from presentations on this review if anyone wishes.The Best to You and Yours!Jon in Nevada------------------------------Date: Wed, 1 Feb 2012 14:20:02 -0500Subject: Re: Surgery Next Week!Marty, if Grimm really has evidence that " Brachy +IMRT yields lowerincidence of sexual dysfunction and lower incidence of incontinence," thenhe should have published his findings in a peer reviewed journal article,not just on his website. I'm sure that the Dr. knows this, so, the onlyconclusion I can draw is that he probably did submit an article and thereviewers rejected it......................... Quote Link to comment Share on other sites More sharing options...
Guest guest Posted February 1, 2012 Report Share Posted February 1, 2012 Just to be clear, the study group (the group of 25 doctors, not just Dr. Grimm) used published studies in compiling their review. They reviewed over 18,000 papers and based their findings on over 800 selected by very restrictive criteria. The Study Group's findings were also published in the PCRI Insights, May 2011: http://prostate-cancer.org/pcricms/sites/default/files/PDFs/Is14-2_p3-11.pdf This included the comparison (with references) of side effects by treatment type that was questioned in a previous post. Among the 11 criteria the study group used in selecting publications to include in their review was that the selected papers had to use these criteria for biochemical failure: " A PSA based, standardized endpoint for treatment failure had to be used. (Biologic Relapse Free Survival – BRFS). Note: Radiation, Cryotherapy, and HIFU use the ASTRO or Phoenix definition of PSA failure. Surgery uses PSA >= 0.2 ng/ml as an indicator failure. " I don't know what definition Grimm uses for his patients. The Study Group Report was not referring to Grimm's practice The two links I provided do not include the keys linking the plotted data points to the publication references. However, I do have a 2011 PowerPoint presentation of the Study Groups slides that does show the source publication for every point in each slide. As I indicated originally, this is the most objective and comprehensive review comparing prostate cancer treatment results that I have found in the past 6 years. The Study Group reportedly intends to provide updates annually. You know guys, there is no way to summarize valid information dealing with our disease in 25 words or less on an Internet post... There are excellent information sources available, but, it does take a bit of effort to read and digest them.... ;-) The Best to You and Yours! Jon in Nevada ------------------------------ Date: Wed, 1 Feb 2012 18:20:32 -0500 Subject: Re: Grimm: treatment outcomes Jon...Do you have Grimm's list of references used to identify the various studies used to create his graphs (e.g. the references that identify the numbers in the graphical symbols)? Can anyone tell me what definition of biochemical failure Grimm uses for his patients?..Thanks, Ron >In the absence of any large-scale published randomized study comparing >prostate cancer treatments, perhaps the most thorough and objective >literature review attempting such a comparison was the one done by the >Prostate Cancer Results Study Group. A summary is on Dr. Grimm's web site: >http://www.prostatecancertreatmentcenter.com/ProstateCancer/ProstateCancerResul\ tsStudyGroup.aspx > >I find it a bit bemusing that this study is often criticized as being >'biased' towards brachytherapy when the results are presented by Drs. Grimm >or Blasko, or shown on a brachytherapy web site. The actual study group >was >composed of 25 highly respected doctors including surgeons, radiologists, >oncologists, and medical researchers. The study group had very restrictive >conditions for inclusion of the studies reviewed-- only those providing >stratification of treatment results by risk group, only studies published >in >peer reviewed journals, only studies meeting a minimum number of patients. >The graphical summaries showing treatment results by risk group are fully >documented with references and are rather eye-opening in the range of >actual >treatment outcomes for each treatment type and risk group. > >As a prostate cancer patient yet to be treated (6 years into Active >Surveillance), and thus as yet having no bias towards MY treatment choice, >I >am following the continuing study by this group with great interest. I can >highly recommend that any man facing the tough issue of chosing treatment >for prostate cancer take a look at the above web site. > >I can provide additional slides from presentations on this review if anyone >wishes. > >The Best to You and Yours! >Jon in Nevada > Quote Link to comment Share on other sites More sharing options...
Guest guest Posted February 4, 2012 Report Share Posted February 4, 2012 Date: Sat, 4 Feb 2012 20:45:13 -0500 Subject: Re: Grimm: treatment outcomes The Prostate Cancer Results Study Group evaluated over 18,000 papers and ended up selecting 848 that met their selection criteria, which are fully documented in the three references provided thus far to this work in past posts. Historically there have been no consistent definitions of biochemical failure (based on PSA) among or even within treatment types. To go through the 848 publications used in ths review and obtain the necessary raw data to back calculate a consistent definition of biochemical failure would be a rather absurd task. Yes, the fact that historical studies have used different definitions of biochemical failure is among the many challenges in trying to conduct such a review. There have been no long-term large-scale random clinical trials comparing prostate cancer treatments, and, given the costs of such a long-term trial and the challenge of having men agree to have randomized treatment, there probably never will be such trials in the future. Available retrospective studies vary greatly in scope and rigor. At one narrow extreme are rather small single-practitioner results comparing robotic to open surgery, which are subject to the bias of selection criteria and surgical techniques of that particular surgeon. How does one translate such results to the local availability of community doctors? The same issues apply to a single doctor or single institution study reporting outcomes of any type of treatment. The Study Group reported by Grimm et al attempted to present a wider review of the range of results from major types of treatment, using well-defined selection criteria, and, importantly in my own view of our disease, stratified by cancer risk. If there are other studies of similar scope and documentation, let's share them. They presented the results in a graphical format which is rather easy to comprehend. Each data point in the graphs represents an entire study, which in an available PowerPoint file is fully referenced in the 'notes' section below each graph. I have posted the PowerPoint file in the Yahoo prostate cancer support group files: http://health.groups.yahoo.com/group/ProstateCancerSupport/files/ with the file name: Grimm.2011.TreatmentComparisonSlides.ppt If there is an alternative site where posting this file would be more inclusive, let me know. The Best to You and Yours! Jon in Nevada Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.